83 related articles for article (PubMed ID: 2195985)
1. Epidermal growth factor receptors in colorectal carcinoma.
Moorghen M; Ince P; Finney KJ; Watson AJ; Harris AL
Anticancer Res; 1990; 10(3):605-11. PubMed ID: 2195985
[TBL] [Abstract][Full Text] [Related]
2. A comparison of biochemical and immunohistochemical assessment of EGFR expression in ovarian cancer.
Owens OJ; Stewart C; Leake RE; McNicol AM
Anticancer Res; 1992; 12(5):1455-8. PubMed ID: 1444207
[TBL] [Abstract][Full Text] [Related]
3. Relationships between oestrogen receptor,epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer.
Horne GM; Angus B; Wright C; Needham G; Nicholson S; Harris AL; Innes B; Horne CH
J Pathol; 1988 Jun; 155(2):143-50. PubMed ID: 3292735
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
[TBL] [Abstract][Full Text] [Related]
5. Ratiometric assay of epidermal growth factor receptor tyrosine kinase activation.
Schooler K; Wiley HS
Anal Biochem; 2000 Jan; 277(1):135-42. PubMed ID: 10610698
[TBL] [Abstract][Full Text] [Related]
6. Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects.
Rodeck U; Herlyn M; Herlyn D; Molthoff C; Atkinson B; Varello M; Steplewski Z; Koprowski H
Cancer Res; 1987 Jul; 47(14):3692-6. PubMed ID: 3297307
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.
Yasui W; Sumiyoshi H; Hata J; Kameda T; Ochiai A; Ito H; Tahara E
Cancer Res; 1988 Jan; 48(1):137-41. PubMed ID: 2446740
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
Komatsu K; Andoh A; Ishiguro S; Suzuki N; Hunai H; Kobune-Fujiwara Y; Kameyama M; Miyoshi J; Akedo H; Nakamura H
Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa.
Maiorano E; Favia G; Maisonneuve P; Viale G
J Pathol; 1998 Jun; 185(2):167-74. PubMed ID: 9713343
[TBL] [Abstract][Full Text] [Related]
11. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ
Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952
[TBL] [Abstract][Full Text] [Related]
12. Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma.
Layfield LJ; Bernard PS; Goldstein NS
J Surg Oncol; 2003 Aug; 83(4):227-31. PubMed ID: 12884235
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical variability of epidermal growth factor receptor (EGFR) in liver metastases from colonic carcinomas.
Bralet MP; Paule B; Falissard B; Adam R; Guettier C
Histopathology; 2007 Jan; 50(2):210-6. PubMed ID: 17222249
[TBL] [Abstract][Full Text] [Related]
14. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
16. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.
Saeki T; Salomon DS; Johnson GR; Gullick WJ; Mandai K; Yamagami K; Moriwaki S; Tanada M; Takashima S; Tahara E
Jpn J Clin Oncol; 1995 Dec; 25(6):240-9. PubMed ID: 8523820
[TBL] [Abstract][Full Text] [Related]
17. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
19. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma.
Lager DJ; Slagel DD; Palechek PL
Mod Pathol; 1994 Jun; 7(5):544-8. PubMed ID: 7937720
[TBL] [Abstract][Full Text] [Related]
20. Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors.
Smith K; Fennelly JA; Neal DE; Hall RR; Harris AL
Cancer Res; 1989 Nov; 49(21):5810-5. PubMed ID: 2790793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
